ストックスクリーナーアプリを入手
65.36
0.46%
0.365
前日終値:
$64.99
開ける：
$64.84
24時間の取引高:
44,965
Relative Volume:
0.11
時価総額：
$3.21B
収益：
$1.11B
当期純損益:
$205.95M
株価収益率:
15.90
EPS:
4.11
ネットキャッシュフロー:
$254.64M
1週間 パフォーマンス:
+2.19%
1か月 パフォーマンス:
-13.83%
6か月 パフォーマンス:
-23.36%
1年 パフォーマンス:
-4.76%
1日の値動き範囲:
$64.53
$65.54
1週間の範囲:
$62.95
$66.57
52週間の値動き範囲:
$62.95
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
名前
Prestige Consumer Healthcare Inc
セクター
電話
(914) 524-6800
住所
660 WHITE PLAINS RD., TARRYTOWN, NY
PBH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
65.27 | 3.20B | 1.11B | 205.95M | 254.64M | 4.11 |
|
ZTS
Zoetis Inc
|
154.68 | 68.30B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.13 | 47.37B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.29B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.04 | 20.49B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
313.81 | 14.16B | 2.99B | 1.21B | 1.13B | 25.06 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-09 | ダウングレード | Sidoti | Buy → Neutral |
| 2024-06-21 | アップグレード | DA Davidson | Neutral → Buy |
| 2022-11-17 | 開始されました | Canaccord Genuity | Buy |
| 2022-05-10 | アップグレード | Jefferies | Hold → Buy |
| 2022-05-09 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-08-07 | ダウングレード | DA Davidson | Buy → Neutral |
| 2020-06-29 | アップグレード | Sidoti | Neutral → Buy |
| 2020-04-14 | ダウングレード | Jefferies | Buy → Hold |
| 2020-04-07 | 再開されました | Sidoti | Neutral |
| 2020-03-26 | アップグレード | Jefferies | Hold → Buy |
| 2020-03-24 | 開始されました | Oppenheimer | Perform |
| 2020-03-19 | アップグレード | DA Davidson | Neutral → Buy |
| 2019-01-15 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | アップグレード | Jefferies | Underperform → Hold |
| 2017-05-22 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | 繰り返されました | B. Riley & Co. | Buy |
| 2016-11-17 | 開始されました | Gabelli & Co | Buy |
| 2016-08-12 | アップグレード | Sidoti | Neutral → Buy |
| 2016-03-08 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | 開始されました | Piper Jaffray | Overweight |
| 2015-11-30 | ダウングレード | Jefferies | Hold → Underperform |
| 2014-04-28 | 繰り返されました | B. Riley & Co. | Buy |
| 2014-04-28 | 繰り返されました | Oppenheimer | Outperform |
| 2013-07-09 | 開始されました | B. Riley & Co. | Buy |
すべてを表示
Prestige Consumer Healthcare Inc (PBH) 最新ニュース
Resistance Break Could Fuel Prestige Consumer Healthcare Inc. Rally2025 Market Trends & Real-Time Sentiment Analysis - beatles.ru
Prestige Consumer Healthcare Inc. shares rise 1.29% intraday due to strong customer demand and operational excellence. - AInvest
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $100 - 富途牛牛
What's the market missing about PBH's earnings potential? - AInvest
Is This a Bottoming Phase for Prestige Consumer Healthcare Inc.Market Activity Report & AI Forecasted Entry and Exit Points - beatles.ru
Prestige Consumer Healthcare Cuts FY22 Revenue Outlook Amid Supply Chain Issues and Retail Order Volatility - AInvest
Prestige Consumer Healthcare (PBH) Trims Outlook as Sales Dip—Is the Acquisition Strategy Still on Track? - simplywall.st
Prestige Consumer Healthcare’s Cautious Earnings Call Outlook - TipRanks
Prestige Consumer Healthcare's Strategic Acquisition and Q1 Earnings: A Value Investment Case in a Resilient OTC Sector - AInvest
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
Prestige Consumer Healthcare Acquires Pillar5 Pharma for Expansion - MSN
Prestige Consumer Healthcare: Analyst Maintains Buy Rating, Lowers Price Target to $100.00 - AInvest
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q1 2026 Earnings Call Transcript - Insider Monkey
Prestige Consumer Starting Clear Eyes Production With No Contract Partner ‘Out There To Tap Into’ - insights.citeline.com
Prestige Consumer Healthcare's Q1 2026: Key Contradictions in Clear Eyes Supply, Market Share, and Margin Outlook - AInvest
Prestige Consumer Healthcare stock hits 52-week low at 64.83 USD By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare stock hits 52-week low at 64.83 USD - Investing.com Nigeria
Prestige Brands stock price target lowered to $100 at Canaccord on eye care supply issues - Investing.com Canada
Prestige Consumer Healthcare's Strategic Path to Recovery: Can Shareholders Capitalize on a Turnaround in Eye Care and Margin Expansion? - AInvest
Prestige Consumer Healthcare: Fiscal Q1 Earnings Snapshot - Manistee News Advocate
Prestige Consumer Healthcare: Strategic Acquisitions and Innovation Drive Long-Term Value Creation - AInvest
Prestige Consumer Healthcare outlines $1.1B-$1.115B FY26 revenue target amid Pillar5 acquisition and Clear Eyes supply recovery - MSN
Prestige Consumer Healthcare 2026 Q1 Earnings Misses Targets as Net Income Falls 3.3% - AInvest
Prestige Consumer Healthcare Q1 Earnings and Strategic Acquisition of Pillar5 Pharma - AInvest
Prestige Consumer Healthcare’s Q1 Earnings and Strategic Moves - TipRanks
Prestige Earnings: Clear Eyes' Constraints Cloud Near-Term Outlook, but Core Portfolio Remains Solid - Morningstar
Prestige Consumer Healthcare Q1 2026 Earnings Call Transcript - MarketBeat
Prestige Consumer Healthcare shares fall 10.14% intraday after missing Q1 revenue estimates and lowering fiscal 2026 outlook. - AInvest
Prestige Consumer Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Prestige Consumer Healthcare Inc. Q1 Profit Decreases, Misses Estimates - Nasdaq
Prestige Consumer Healthcare Plummets 10.5%: Earnings Shock and Sector Turbulence Ignite Sell-Off - AInvest
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Prestige Consumer Healthcare's Strategic Acquisition of Anjac SAS: A Catalyst for OTC Men's Health Dominance - AInvest
Prestige Consumer Healthcare Eyes Growth Despite Revenue Shortfall - Finimize
Prestige Consumer Healthcare on Aug 4, unit entered agreement with Anjac SASSEC filing - MarketScreener
Prestige Consumer Healthcare Q1 FY26 slides: Revenue drops on supply issues, margins improve - Investing.com Nigeria
Prestige Consumer Healthcare Q1 FY26 slides: Revenue drops on supply issues, margins improve By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue Estimates - Yahoo Finance
Prestige Consumer Healthcare Q1 Revenue Falls 6.6% Amid Supply Constraints and Order Timing Shifts - AInvest
Prestige Consumer Healthcare's Strategic Acquisition of Pillar5 Pharma: A Masterstroke in Supply Chain Resilience and Competitive Edge - AInvest
Prestige Consumer Healthcare Reports Lower Q1 Earnings Than ExpectedNews and Statistics - IndexBox
Prestige (PBH) Q1 Revenue Falls 6.6% - The Globe and Mail
Prestige Consumer's Strategic Turnaround: Assessing Brand Resilience and M&A-Driven Growth in a High-Margin Sector - AInvest
Prestige Consumer Healthcare Inc. SEC 10-Q Report - TradingView
Prestige Consumer misses Q1 revenue estimates, to acquire Pillar5 Pharma - MarketScreener
Prestige Consumer Healthcare's Fiscal 2026 Q1 Earnings: A Strategic Masterclass in Brand Diversification and Operational Excellence - AInvest
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results - GlobeNewswire
Prestige Healthcare Reports Mixed Q1 Results, Makes Strategic Eye Care Supplier Acquisition - Stock Titan
Prestige Consumer Healthcare Inc (PBH) 財務データ
収益
当期純利益
現金流量
EPS
0.15%
0.53%
大文字化:
|
ボリューム (24 時間):